Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 03-1995 | 03-1994 | 03-1993 | 03-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 6,926 | -6,878 | 2,207 | 2,335 |
| Depreciation Amortization | 0 | 2,343 | 2,540 | 2,558 | 2,277 |
| Other Working Capital | 0 | -251 | -17,111 | -5,822 | 7,132 |
| Other Operating Activity | 0 | 556 | 11,854 | 301 | -348 |
| Operating Cash Flow | $0 | $9,574 | $-9,595 | $-756 | $11,396 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -2,529 | -2,698 | -4,302 | -1,509 |
| Net Acquisitions | 0 | 0 | 0 | -594 | 0 |
| Other Investing Activity | 0 | -145 | 1,550 | 0 | 0 |
| Investing Cash Flow | $0 | $-2,674 | $-1,148 | $-4,896 | $-1,509 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | -3,823 | -251 | 0 |
| Other Financing Activity | 0 | -4,538 | 12,676 | 7,161 | -8,930 |
| Financing Cash Flow | $0 | $-4,538 | $8,853 | $6,910 | $-8,930 |
| Exchange Rate Effect | 0 | -28 | -82 | -73 | -34 |
| Beginning Cash Position | 0 | 612 | 2,584 | 1,399 | 476 |
| End Cash Position | 0 | 2,946 | 612 | 2,584 | 1,399 |
| Net Cash Flow | $0 | $2,362 | $-1,972 | $1,185 | $923 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 9,574 | -9,595 | -756 | 11,396 |
| Free Cash Flow | 0 | 9,574 | -9,595 | -756 | 11,396 |